Use of Biomarkers in ALS Drug Development and Clinical Trials

Brain Research - Netherlands
doi 10.1016/j.brainres.2014.10.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Characterization of Renal Biomarkers for Use in Clinical Trials: Biomarker Evaluation in Healthy Volunteers

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

Analysis of Clinical Drug Trials in Children Compared to Clinical Drug Trials in Adults, in Argentina

Archivos Argentinos de Pediatria
Child HealthPediatricsPerinatology
2019English

Biomarkers in Oncology Drug Development

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2008English

Biomarkers Inform Clinical Trials and Pathogenesis in Systemic Sclerosis

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2010English

Analysis of Start-Up, Retention, and Adherence in ALS Clinical Trials

Neurology
Neurology
2013English

Development of Standard Clinical Endpoints for Use in Dengue Interventional Trials

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2018English

ALS Drug Development Guidances and Trial Guidelines

Neurology
Neurology
2019English

Novel Cardiovascular Biomarkers and Implications for Clinical Trials

Nature Clinical Practice Cardiovascular Medicine
2006English

Development of Dietary Phytochemical Chemopreventive Agents: Biomarkers and Choice of Dose for Early Clinical Trials

Cancer Prevention Research
MedicineCancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy